Rob Philibert MD PhD is the Chief Medical Officer and co-founder of Cardio Diagnostics. Dr. Philibert graduated from the University of Iowa Medical Scientist Training Program and completed a residency in Psychiatry at the University of Iowa. Between 1993-1998, he completed a Pharmacology Research Training Program (PRAT) Fellowship and a Staff Fellowship at the National Institutes of Health while also serving in the United States Uniformed Public Health Service. In late 1998, he returned to the University of Iowa where he now is a Professor of Psychiatry with joint appointments in Neuroscience, Molecular Medicine, and Biomedical Engineering. He has published over 170 peer-reviewed manuscripts and is the recipient of numerous NIH grant awards and both national and international patents for his pioneering work in epigenetics. In particular, he is credited with discovering the epigenetic signatures for cigarette and alcohol consumption. In 2009, he founded Behavioral Diagnostics LLC, a leading provider of epigenetic testing services. Critically, he has raised over $6 million in non- dilutive funding for Behavioral Diagnostics and has introduced two epigenetic tests, Smoke Signature© and Alcohol Signature™ to the commercial market. Simultaneously, he has licensed related non-core technologies to manufacturing partners while developing an ecosystem of key complementary service providers in the clinical diagnostics space. In 2017, together with Dr. Dogan, he founded Cardio Diagnostics where he serves as Chief Medical Officer.